Team

Principal Investigators

John Gore, MD, MS, University of Washington

Angela Smith, MD, MS, University of North Carolina

Study Management

Program Director: Erika Wolff, PhD, University of Washington

Senior Project Manager: On Ho, PhD, University of Washington

Clinical Coordinating Center

Director: John Gore, MD, MS, University of Washington

Project Manager: Kristin Follmer, University of Washington

Data Coordinating Center

Director: Bryan Comstock, MS, University of Washington

Lead Biostatistician: Michael Nash, MS, University of Washington  

Stakeholder Coordinating Center

Director: Angela Smith, MD, MS, University of North Carolina

Senior Project Manager: Sarah Lawrence, MA, University of Washington

Executive Committee

The Executive Committee provides governance for scientific decisions related to design, measurement, and analytic issues in this project as well as pragmatic issues around study recruitment and patient experience. In addition, they will participate in the dissemination of project findings, including publications in scientific journals and presentations at regional and national meetings.

Chair: Larry Kessler, ScD, University of Washington

Co-PIs: John Gore, MD, MS, University of Washington; Angela Smith, MD, MS, University of North Carolina

Co-Investigators: Erika Wolff, PhD, University of Washington; Danielle Lavallee, PharmD, PhD, University of Washington; Bryan Comstock, MS, University of Washington

Community Urologist Stakeholder: Tullika Garg, MD, MPH, Geisinger

AUA Guidelines Stakeholder: Sam Chang, MD, MBA, Vanderbilt University  

Advocate Stakeholder: Stephanie Chisolm, PhD, Bladder Cancer Advisory Network (BCAN)

Advocate Advisory Board

The Advocate Advisory Board provides guidance in the design and implementation of the study, and ensures the “patient voice” is incorporated into issues that are meaningful to bladder cancer patients.

Chair: Stephanie Chisolm, PhD, Bladder Cancer Advocacy Network (BCAN)

Members: Fred Almeida, Mary Beth Ballard, Domenic Grignano, Lynnda Hoefler, Robert Lipman, Renata Louwers, Douglas MacLean, Karen Sachse

External Advisory Board

The External Advisory Board supports the national outreach, dissemination and implementation of the results by providing a national perspective on metrics, approaches, materials and messages related to the study.  

Co-PIs: John Gore, MD, MS, University of Washington; Angela Smith, MD, MS, University of North Carolina

Co-Investigators: Erika Wolff, PhD, University of Washington; Danielle Lavallee, PharmD, PhD, University of Washington

Advocate Stakeholder: Stephanie Chisolm, PhD, Bladder Cancer Advisory Network (BCAN)

Clinician Stakeholders:  Sima Porten, MD, MPH, UCSF; Yair Lotan, MD, UT Southwestern Medical Center; James Catto, MD, ChB, PhD, University of Sheffield

NCCN Guidelines Stakeholder: Tracy Downs, MD, FACS, University of Wisconsin

Healthcare Stakeholder: Jennifer Malin, MD, UnitedHealth

Industry Stakeholder: Ewan Gibb, PhD, Decipher Biosciences